LNG exporter Venture Global slashes IPO price range

Venture Global LNG raises $1.75 billion after pricing US IPO
Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering within range, the second-largest exporter of liquefied natural gas in the United States said on Thursday. The company priced its offering of 70 million shares at $25 each,
US energy group Venture Global notches up $60bn valuation in IPO
The company priced its IPO at $25 a share, raising $1.75bn, according to a statement. It had said earlier this month that it was seeking to achieve a valuation of up to $110bn — more than oil major BP — before scaling back its offering this week.
Venture Global Slashes IPO Price Range by More Than 40%
Venture Global Inc. slashed the marketed range for its initial public offering, lowering the market value it could fetch.
LNG exporter Venture Global cuts target valuation for US IPO to $65.3 billion
Venture Global LNG on Wednesday slashed the valuation it sought from a U.S. initial public offering to $65.33 billion, significantly lower than the initial target of $110 billion.
LNG exporter Venture Global slashes IPO valuation target by $45B after investors balk
Liquefied natural gas producer Venture Global slashed the proposed range for its IPO on Wednesday, lowering the valuation it sought to ~$65B from the initial target of $110B at the top of the previous range.
Venture Global LNG reportedly considering lowering US IPO price range
The company plans to increase its share offering from 50 million to up to 62 million in its potential New York flotation.
Venture Global LNG raises $1.75 bln after pricing US IPO
Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering, the second-largest exporter of liquefied natural gas in the United States said on Thursday.
Philippine water company Maynilad hires banks for over $500 million IPO, sources say
Maynilad Water Services has hired banks including Morgan Stanley and UBS to work on a more than $500 million initial public ...
Diabetes startup Virta Health is now prescribing Ozempic for weight loss in a push toward profitability and IPO
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
Travel App Hopper Eyes Long-Term IPO Plan, $10 Billion Valuation
Travel data provider Hopper Inc., one of Canada’s largest closely held technology companies, is eyeing a public listing that ...
ANG.PR.D: A 7.375% Preferred Shares IPO From American National Group
Financial analysis of American National Group's preferred stock ANG-D reveals concerns about dividend payments and market ...
BioPharma Dive48m
Ascentage prices first biotech IPO of 2025, raising $126M
The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.
IPO-bound Infra.Market raises $121 million
Infra.Market, a profitable B2B startup founded in 2016, has raised $121 million at a valuation of $2.8 billion in a pre-IPO ...
Odyssey Therapeutics Begins IPO Rollout
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
Tata IPO: Will Tata Group Launch Mother Of All IPOs In India? Pressure On Tata Sons Mount To List!
As long as Tata Sons cannot deregister itself as NBFC, the listing criteria of RBIs NBFCs in the Upper Layer (NBFC-UL) rule will hang on the company. If it does manage to deregister, then it can avoid ...